*  DNA vaccination
Second generation vaccines were developed to reduce the risks from live vaccines. These are subunit vaccines, consisting of ... "Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated ... First generation vaccines are whole-organism vaccines - either live and weakened, or killed forms. Live, attenuated vaccines, ... A veterinary DNA vaccine to protect horses from West Nile virus has been approved. DNA vaccines elicit the best immune response ...
*  Vaccine-preventable diseases
Four diseases were responsible for 98% of vaccine-preventable deaths: measles, Haemophilus influenzae serotype b, pertussis, ... Vaccine-preventable deaths are usually caused by a failure to obtain the vaccine in a timely manner. This may be due to ... If a vaccine-preventable disease is uncommon in a country, then residents of that country are unlikely to receive a vaccine ... A vaccine-preventable disease is an infectious disease for which an effective preventive vaccine exists. If a person acquires a ...
*  Mumps
The vaccine may be given separately or as part of the MMR immunization vaccine that also protects against measles and rubella. ... Some anti-vaccine activists protest against the administration of a vaccine against mumps, claiming that the attenuated vaccine ... and rubella virus vaccines. JAMA. 207. pp. 2259-62. PMID 5818433. MMR Vaccine (PDF) (PDF), Vaccine Information Statement, ... Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C (2012). "Vaccines for measles, mumps and rubella in children". Cochrane ...
*  Measles vaccine
Two types of measles vaccines are currently available. Mumps Measles Rubella vaccine, live (MMR-II) Mumps Measles Rubella and ... Measles mumps rubella vaccine (MMR-II); MMR vaccine is a live attenuated viral vaccine used to induce immunity against measles ... The vaccine may also protect against measles if given within a couple of days of exposure to measles. The vaccine is generally ... Measles vaccine is a vaccine that prevents measles. After one dose 85% of children nine months of age and 95% over twelve ...
*  DMOZ - Health: Pharmacy: Drugs and Medications: M: Measles Virus Vaccine
"Health ... Measles Virus Vaccine" search on: AOL - Ask - Bing - DuckDuckGo - Gigablast - Google - ixquick - Yahoo - Yandex - ...
*  Anna Mitus
... was a medical researcher best known for her work on the measles vaccine as a part of the John Enders lab. Her most ... Nicholas, Bakalar (October 4, 2010). "Measles Vaccine, 1960". The New York Times. Enders, J.F. (1991). Biographical Memoirs V. ... Overall, Mitus published at least 9 peer-reviewed journal articles on measles and the measles virus. On October 1, 1961, John ... "Persistence of Measles Virus and Depression of Antibody Formation in Patients with Giant-Cell Pneumonia after Measles". The New ...
*  John Franklin Enders
In 1963, Pfizer introduced a deactivated measles vaccine, and Merck & Co introduced an attenuated measles vaccine. 1946: Fellow ... "The first measles vaccine". Pediatrics. 128 (3): 435-7. doi:10.1542/peds.2011-1430. Bakalar N, "First mention: Measles vaccine ... Katz SL (2009). "John F. Enders and measles virus vaccine-a reminiscence". Measles. Current Topics in Microbiology and ... On September 17, 1961, The New York Times announced the measles vaccine effective. Refusing credit for only himself, Enders ...
*  Pollin Prize for Pediatric Research
Samuel L. Katz For His Role In Developing Measles Vaccine". Medical News Today. 2007-04-13. Retrieved 2009-03-14. Dr. Samuel L ... Astigarraga, Carolina (2007-04-20). "Prof honored for measles vaccine - News". Retrieved 2009-03-14. For this and many other ... especially his instrumental role in the development and application of the measles vaccine "Pollin Pediatric Research Prize ... the recipient of the 2007 Pollin Prize in recognition of his contributions to pediatric infectious disease research and vaccine ...
*  Davi Kopenawa Yanomami
Ý Redd, S. C.; L.E. Markowitz; and S. L. Katz, 1999,Ý "Measles Vaccine." Ý In Vaccines, ed. Plotkin and Oresten (W. B. Saunders ... "Although death because of measles is rare in the United States and Europe, in developing countries death rates from measles can ... His wife lost much of her family to measles and other diseases brought to the area in the 1970s by road construction crews and ... reach as high as 15%. Of these deaths, 60% result from secondary infections of bacterial pneumonia attendant upon measles. ( ...
*  Treato
"Frequency of measles vaccine discussions rises by 500%". vaccine news daily. Retrieved 5 January 2016. "Treato Launches Social ...
*  Mady Hornig
In 2008, she published a study concluding that there was no association between presence of measles vaccine virus in the gut of ... "Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study". PLoS ONE. 3 (9): e3140. ... Rubenstein, Sarah (8 September 2008). "Study Shows 'No Connection' Between Measles Vaccine, Autism". Wall Street Journal. ... Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study', PLoS ONE (September, 2008 ...
*  Bandim Health Project
One of the most important findings was that a new measles vaccine used in low-income countries was associated with a two-fold ... "Expanded programme on immunization (EPI). Safety of high titre measles vaccines". Wkly Epidemiol Rec. 67: 1992. PMID 1449986. ... "Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with ... This discovery led to the withdrawal of the vaccine. Had it not been withdrawn, it could have cost at least ½ million ...
*  Measles
The measles vaccine is effective at preventing the disease. Vaccination has resulted in a 75% decrease in deaths from measles ... An improved measles vaccine became available in 1968. Measles as an endemic disease was eliminated from the United States in ... Initiative for Vaccine Research (IVR): Measles, World Health Organization (WHO) Measles FAQ from Centers for Disease Control ... Vaccine. 30 (41): 5905-13. doi:10.1016/j.vaccine.2012.07.035. PMID 22841972. "Bug of the Month-Measles". Banner Gateway Medical ...
*  International Centre for Diarrhoeal Disease Research, Bangladesh
Benefit of measles vaccine demonstrated, leading to inclusion in EPI. 1985: Cholera vaccine trial launched. 1988: Treatment of ... 2001: Oral cholera vaccine, tested at icddr,b, is approved for use by WHO. 2001: Studies on the effects of arsenic on health ... 2007: Oral cholera vaccine Dukoral, tested at Matlab in 1985, launched in Bangladesh. 2008: Introduce SHEBA (an integrated ... 1974: Tetanus toxoid vaccine recommended for pregnant women, reducing neonatal mortality by 30%. 1978: Rotavirus identified as ...
*  Thomas C. Peebles
In the late 1950s and early 1960s, nearly twice as many children died from measles as from polio. The vaccine for measles has ... formed the basis for the development of the present vaccine". Staff. "The Measles Vaccine", The New York Times, March 28, 1963 ... Enders was able to use the cultivated virus to develop a measles vaccine in 1963 based on the material isolated by Peebles. ... "Work by Enders Brings Measles Vaccine License", The Hartford Courant, March 22, 1963. Accessed August 4, 2010. "A strain of ...
*  Viera Scheibner
Scheibner, Viera (29 January 2013) "Measles Vaccines Part II; Benefits of Contracting Measles", International Medical Council ... in particular in regard to measles vaccinations and the DPT vaccine - are not supported by scientific evidence, and concludes ... Vaccine. 25 (26): 4875-4879. doi:10.1016/j.vaccine.2007.02.077. PMID 17400342. CS1 maint: Multiple names: authors list (link) ... Scheibner has stated that infection with diseases such as polio, measles, whooping Cough and rubella are best managed through ...
*  Transmission-based precautions
Measles vaccination after exposure to natural measles. J Pediatr 1978;93(1):43-6. CDC. Measles, mumps, and rubella--vaccine use ... Secondary measles vaccine failure in healthcare workers exposed to infected patients. Infect Control Hosp Epidemiol 1993;14(2): ... Whenever possible, non-immune HCWs should not care for patients with vaccine-preventable airborne diseases (e.g., measles, ... Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep ...
*  Samuel Katz (pediatrician)
October 15, 1958 the first Measles Vaccine is tested in a Boston lab. The first version of the lab's vaccine on mentally ... "Measles - Timelines - History of Vaccines". www.historyofvaccines.org. Retrieved 2016-08-16. "Samuel L. Katz, MD, To Receive ... He remained with Enders for 12 years during which time they developed the attenuated measles virus vaccine now used throughout ... the Vaccine Priorities Study of the Institute of Medicine (IOM), and several WHO and CVI vaccine and HIV panels. He is a member ...
*  1758 in science
Scottish physician Francis Home makes the first attempt to deliver a measles vaccine. Ruđer Bošković publishes his atomic ... Enders, J. F. (December 1961 - February 1962). "Vaccination against measles: Francis Home redivivus". Yale Journal of Biology ...
*  Epidemiology of measles
Measles is a leading cause of vaccine-preventable childhood mortality. Worldwide, the fatality rate has been significantly ... WHO: Global summary on measles, 2006 Measles Surveillance Data after WHO, last updated 2014-3-6 Measles reported cases by WHO ... "Anti-vaccine groups blamed in Minnesota measles outbreak". CNN. Retrieved 2017-05-26. "Unfounded Autism Fears Are Fueling ... Eleven of the cases had received at least one dose of measles vaccine. Children who were unvaccinated or whose vaccination ...
*  Breakthrough infection
The mumps vaccine is a component of the Measles, Mumps and Rubella vaccine (MMR). The mumps vaccine, specifically, is 88% ... The common flu vaccine is estimated to provide immunity to the flu in 58% of recipients. The measles vaccine fails to provide ... Vaccines may fail to provide immunity if the vaccine is of poor quality when administered. A vaccine loses potency if it is ... Indeed, vaccines, including the influenza vaccine, Tdap, and pneumococcal vaccines, are less effective in adults over the age ...
*  David Morley (paediatrician)
Morley started the earliest trials of the measles vaccine, in which he included his own children. He also devised an asthma ... Morley, David (1 February 1969). "Severe Measles in the Tropics" (PDF). Br Med J. 1 (5639): 297-300. doi:10.1136/bmj.1.5639.297 ... and first became interested in measles and growth monitoring. In 1973 he wrote of Nigeria "Three-quarters of our population are ...
*  Dengue virus
Brandler, S; Ruffie, C; Najburg, V; Frenkiel, MP; Bedouelle, H; Desprès, P; Tangy, F (Sep 2010). "Pediatric measles vaccine ... One vaccine was in phase III trials in 2012 and planning for vaccine usage and effectiveness surveillance had started. In 2009 ... Only one vaccine for dengue is currently approved in three countries (Brazil, Mexico, Philippines). Several vaccines are under ... Vaccine Development, Dengue Vaccine Initiative, November 2012, accessed November 5, 2013 Schmaljohn, Alan L.; McClain, David ( ...
*  Prenatal care in the United States
... use of MMR vaccine or measles vaccine is not recommended during pregnancy. Susceptible pregnant women should be vaccinated as ... live attenuated influenza vaccines such as the nasal spray vaccine is not recommended in pregnancy. Preservative-free vaccines ... All postpartum women who have not received Td or Tdap vaccine in the last two years are recommended to receive Tdap prior to ... It is recommended for pregnant women who have never received tetanus vaccine (i.e., have never received DTP, DTaP or DT as ...
*  Rubella
Often it is given in combination with the measles vaccine and mumps vaccine, known as the MMR vaccine. When some, but less than ... In 1969 a live attenuated virus vaccine was licensed. In the early 1970s, a triple vaccine containing attenuated measles, mumps ... Since no vaccine was yet available, some popular magazines promoted the idea of "German measles parties" for infected children ... The vaccine is now usually given as part of the MMR vaccine. The WHO recommends the first dose be given at 12 to 18 months of ...
*  Helen Rees
... and HIV vaccines, and vaccine use in humanitarian emergencies. She is a member of the SAGE Working Group on Measles and Rubella ... She chaired the WHO Committee on the STV Vaccine Roadmap and continues to advise WHO on STI vaccine development and on STI ... She is the current Chair of the WHO SAGE Working Group on Ebola Vaccines, the TFI Working group on Ebola and she chaired the ... and of the SAGE Working Group monitoring the progress of the Global Vaccine Action Plan, the chair of the WHO/PATH Advisory ...
*  HLA-A1
A more recent paper showed an association of A*0101 with lower than average responses to measles vaccine. With rubella, A1-B8 ... A1 with B8 showed an increase risk of measles infection, however, the significance was not consistent. ... "Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses". ...